PT  - JOURNAL ARTICLE
AU  - Jørgensen, Morten W.N.
AU  - Høiby, Niels
AU  - Ziock, Hans J.
AU  - Rasmussen, Steen
TI  - SARS-CoV-2 pandemic dynamics and infection tracing in Denmark
AID  - 10.1101/2021.03.15.21253582
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.15.21253582
4099  - http://medrxiv.org/content/early/2021/03/24/2021.03.15.21253582.short
4100  - http://medrxiv.org/content/early/2021/03/24/2021.03.15.21253582.full
AB  - We model and simulate the COVID-19 infection and healthcare dynamics in Denmark from the onset till March 5, 2021. The simulation is matched and calibrated to hospital and death data as well as antibody population measurement. In this work we focus on comparing the time evolution of the estimated infection level with the daily identified infected individuals based on the national testing and contact tracing program. We find that the national testing program on average identifies 1/3 of the infected individuals July 1, 2020 - March 5, 2021. Our investigations indicate the current program does not have a proper balance between random probing, focused contact tracing, and testing prioritization. Too much of the program operates as a semi-random daily sampling of part of the population. We propose a policy with a focus on local infection tracing and interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received (no funding from third parties). Funding was provided by independent university salaries.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have followed all appropriate reseatch reporting guidelinesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll used data are publicly avilable and pointers to data are clearly stated in the references of the paper. https://www.ssi.dk https://www.stps.dk https://www.dr.dk